FDA Drug Application (012193) for SER-AP-ES by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number012193
Product Number005
FormTABLET;ORAL
Dosage25MG;15MG;0.1MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSER-AP-ES
Active IngredientHYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE

Active IngredientCount
List of drugs with Active Ingredient HYDRALAZINE HYDROCHLORIDE27
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient RESERPINE52


Back to FDA Applications sponsored by NOVARTIS